# SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

> **NCT00307047** · PHASE3 · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 3687 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** XIENCE V® Everolimus Eluting Coronary Stent
- **DEVICE:** TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent

## Key facts

- **NCT ID:** NCT00307047
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-08
- **Final completion:** 2012-05
- **Target enrollment:** 3687 (ACTUAL)
- **Last updated:** 2012-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00307047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00307047, "SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00307047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*